Skip to content

Intervention measures and curative effect evaluation of coal workers' pneumoconiosis

Intervention measures and curative effect evaluation of coal workers' pneumoconiosis

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050555
Enrollment
Unknown
Registered
2021-08-28
Start date
2021-10-01
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coal workers' pneumoconiosis

Interventions

Experimental group1:Pirfenidone
Experimental group2:Tetrandrine
Experimental group3:Bromhexine Hydrochloride
Experimental group4:Mass lung lavage
Control Group:None

Sponsors

The First Hospital of Shanxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 70 years (including 18 years and 70 years), gender is not limited; 2. Have a clear occupational history, in line with GBZTO-2015 "Diagnosis of Occupational Pneumoconiosis"; 3. The disease is in a stable stage, with symptoms of respiratory impairment, decreased exercise tolerance, and limited daily activities; 4. Able to complete pulmonary function test; 5. The patients voluntarily participated in this trial, with good compliance, and had the ability to understand and sign the informed consent form before the study.

Exclusion criteria

Exclusion criteria: 1. ALT or AST > 3 times ULN; 2. TBiL>1.5 times ULN; 3. Creatinine clearance rate <30 mL/min; 4. Acute respiratory infection; 5. Patients with other clinically significant abnormalities in the lungs; 6. Hypersensitivity to the test drug or its components; 7. Patients with severe cardiovascular disease; 8. Patients with mental illness; 9. Those who have participated in clinical trials of other drugs within 3 months; 10. Those who are judged by the investigator to be unfit to participate in the trial.

Design outcomes

Primary

MeasureTime frame
Pulmonary fuction test;

Secondary

MeasureTime frame
Questionaire survey data;Imaging data;

Countries

China

Contacts

Public ContactZhang Xinri

The First Hospital of Shanxi Medical University

ykdzxr61@163.com+86 13934519071

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026